Ramadass Mahalakshmi, Catz Sergio D
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Immunol Rev. 2016 Sep;273(1):249-65. doi: 10.1111/imr.12452.
Neutrophils constitute the first line of cellular defense against invading microorganisms and modulate the subsequent innate and adaptive immune responses. In order to execute a rapid and precise response to infections, neutrophils rely on preformed effector molecules stored in a variety of intracellular granules. Neutrophil granules contain microbicidal factors, the membrane-bound components of the respiratory burst oxidase, membrane-bound adhesion molecules, and receptors that facilitate the execution of all neutrophil functions including adhesion, transmigration, phagocytosis, degranulation, and neutrophil extracellular trap formation. The rapid mobilization of intracellular organelles is regulated by vesicular trafficking mechanisms controlled by effector molecules that include small GTPases and their interacting proteins. In this review, we focus on recent discoveries of mechanistic processes that are at center stage of the regulation of neutrophil function, highlighting the discrete and selective pathways controlled by trafficking modulators. In particular, we describe novel pathways controlled by the Rab27a effectors JFC1 and Munc13-4 in the regulation of degranulation, reactive oxygen species and neutrophil extracellular trap production, and endolysosomal signaling. Finally, we discuss the importance of understanding these molecular mechanisms in order to design novel approaches to modulate neutrophil-mediated inflammatory processes in a targeted fashion.
中性粒细胞构成了抵御入侵微生物的第一道细胞防线,并调节随后的固有免疫和适应性免疫反应。为了对感染做出快速而精确的反应,中性粒细胞依赖于储存在各种细胞内颗粒中的预先形成的效应分子。中性粒细胞颗粒含有杀菌因子、呼吸爆发氧化酶的膜结合成分、膜结合黏附分子以及促进所有中性粒细胞功能(包括黏附、迁移、吞噬、脱颗粒和中性粒细胞胞外陷阱形成)执行的受体。细胞内细胞器的快速动员由包括小GTP酶及其相互作用蛋白在内的效应分子控制的囊泡运输机制调节。在本综述中,我们重点关注中性粒细胞功能调节核心机制过程的最新发现,强调由运输调节剂控制的离散和选择性途径。特别是,我们描述了Rab27a效应器JFC1和Munc13-4在调节脱颗粒、活性氧和中性粒细胞胞外陷阱产生以及内溶酶体信号传导方面控制的新途径。最后,我们讨论了理解这些分子机制对于设计以靶向方式调节中性粒细胞介导的炎症过程的新方法的重要性。